Skip to main content
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2000 Aug;37(8):579–580. doi: 10.1136/jmg.37.8.579

Identification of four novel PMM2 mutations in congenital disorders of glycosylation (CDG) Ia French patients

S Vuillaumier-Barro 1, G Hetet 1, A Barnier 1, T Dupre 1, M Cuer 1, P de Lonlay 1, V Cormier-Daire 1, G Durand 1, B Grandchamp 1, N Seta 1
PMCID: PMC1734666  PMID: 10922383

Abstract

We screened 11 unrelated French patients with congenital disorders of glycosylation (CDG) Ia for PMM2 mutations. Twenty one missense mutations on the 22 chromosomes (95%) including four novel mutations were identified: C9Y (G26A) in exon 1, L32R (TA95GC) in exon 2, and T226S (C677G) and C241S (G722C) in exon 8. We studied the PMM activity of these four novel mutant proteins and of the R141H mutant protein in an E coli expression system. The T226S, C9Y, L32R, and C241S mutant proteins have decreased specific activity (23 to 41% of normal), are all more or less thermolabile, and R141H has no detectable activity. Our results indicate that the new mutations identified here are less severe than the inactive R141H mutant protein, conferring residual PMM activity compatible with life.


Keywords: CDG; phosphomannomutase; PMM2 mutations

Full Text

The Full Text of this article is available as a PDF (91.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Kjaergaard S., Skovby F., Schwartz M. Absence of homozygosity for predominant mutations in PMM2 in Danish patients with carbohydrate-deficient glycoprotein syndrome type 1. Eur J Hum Genet. 1998 Jul-Aug;6(4):331–336. doi: 10.1038/sj.ejhg.5200194. [DOI] [PubMed] [Google Scholar]
  2. Kondo I., Mizugishi K., Yoneda Y., Hashimoto T., Kuwajima K., Yuasa I., Shigemoto K., Kuroda Y. Missense mutations in phosphomannomutase 2 gene in two Japanese families with carbohydrate-deficient glycoprotein syndrome type 1. Clin Genet. 1999 Jan;55(1):50–54. doi: 10.1034/j.1399-0004.1999.550109.x. [DOI] [PubMed] [Google Scholar]
  3. Matthijs G., Schollen E., Pardon E., Veiga-Da-Cunha M., Jaeken J., Cassiman J. J., Van Schaftingen E. Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome). Nat Genet. 1997 May;16(1):88–92. doi: 10.1038/ng0597-88. [DOI] [PubMed] [Google Scholar]
  4. Matthijs G., Schollen E., Van Schaftingen E., Cassiman J. J., Jaeken J. Lack of homozygotes for the most frequent disease allele in carbohydrate-deficient glycoprotein syndrome type 1A. Am J Hum Genet. 1998 Mar;62(3):542–550. doi: 10.1086/301763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Pirard M., Matthijs G., Heykants L., Schollen E., Grünewald S., Jaeken J., van Schaftingen E. Effect of mutations found in carbohydrate-deficient glycoprotein syndrome type IA on the activity of phosphomannomutase 2. FEBS Lett. 1999 Jun 11;452(3):319–322. doi: 10.1016/s0014-5793(99)00673-0. [DOI] [PubMed] [Google Scholar]
  6. Van Schaftingen E., Jaeken J. Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I. FEBS Lett. 1995 Dec 27;377(3):318–320. doi: 10.1016/0014-5793(95)01357-1. [DOI] [PubMed] [Google Scholar]
  7. Vuillaumier-Barrot S., Barnier A., Cuer M., Durand G., Grandchamp B., Seta N. Characterization of the 415G>A (E139K) PMM2 mutation in carbohydrate-deficient glycoprotein syndrome type Ia disrupting a splicing enhancer resulting in exon 5 skipping. Hum Mutat. 1999 Dec;14(6):543–544. doi: 10.1002/(SICI)1098-1004(199912)14:6<543::AID-HUMU17>3.0.CO;2-S. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES